Table 1 Analysis of the correlation between FBP1 expression and clinicopathological data.

From: Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression

Clinical Characteristics

Case

FBP1 Expression

χ2

P value

High (%)

Low (%)

Sex

 men

78

27 (34.6)

51 (65.4)

0.008

0.931

 women

12

4 (33.3)

8 (66.7)

  

Age

 ≤50

30

8 (26.7)

23 (73.3)

1.206

0.272

 >50

60

23 (38.3)

36 (31.7)

  

Tumor size

 ≤3 cm

20

12 (60.0)

8 (40.0)

7.980

0.005

 >3 cm

69

18 (26.1)

51 (73.9)

  

Pathology stage

 I-II

56

23 (41.1)

33 (58.9)

2.883

0.090

 III-IV

34

8 (23.5)

26 (76.5)

  

AJCC stage

 I-II

43

22 (51.2)

19 (48.8)

10.471

0.001

 III-IV

44

10 (18.2)

39 (81.8)

  

Cirrhosis

 yes

33

13 (39.4)

20 (60.6)

0.565

0.452

 no

57

18 (31.6)

39 (68.4)

  
  1. Some of the information is missing, including one case for tumor size and three cases for AJCC classification.